asparaginase erwinia chrysanthemi (recombinant)-rywn
Drug Details
- Generic Name
- asparaginase erwinia chrysanthemi (recombinant)-rywn
- Brand Names
- Rylaze
- Application Number
- BLA761179
- Sponsor
- Patheon Manufacturing Services LLC
- NDC Codes
- 2
- Dosage Forms
- INJECTION
- Routes
- INTRAMUSCULAR
- Active Ingredients
- ASPARAGINASE
Indications and Usage
1 INDICATIONS AND USAGE RYLAZE is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase. RYLAZE is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase. ( 1 )